TARO PHARMACEUTICALS CANADA Revenue and Competitors

Toronto, ON Canada

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • TARO PHARMACEUTICALS CANADA's estimated annual revenue is currently $20.9M per year.(i)
  • TARO PHARMACEUTICALS CANADA's estimated revenue per employee is $201,000

Employee Data

  • TARO PHARMACEUTICALS CANADA has 104 Employees.(i)
  • TARO PHARMACEUTICALS CANADA grew their employee count by 30% last year.

TARO PHARMACEUTICALS CANADA's People

NameTitleEmail/Phone
1
Senior Regulatory Affairs AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$18.5M92-1%N/AN/A
#2
$14.3M716%N/AN/A
#3
$36M1798%N/AN/A
#4
$7.8M398%N/AN/A
#5
$17.9M933%$192.2MN/A
#6
$64.9M3234%N/AN/A
#7
$0.5M5-55%N/AN/A
#8
$6.8M34-41%N/AN/A
#9
$19.5M9723%N/AN/A
#10
$2.5M2519%N/AN/A
Add Company

What Is TARO PHARMACEUTICALS CANADA?

We are a global, research-driven, specialty pharmaceutical company. Established in 1950, Taro develops, manufactures and markets affordable prescription and over-the counter medications. With support from our parent company, Sun Pharma, the world's 5th largest specialty generic pharmaceutical company we are a powerful global presence. Our world class production facilities in Brampton, Ontario and nearly 600 Canadian employees give Taro Canada a uniquely Canadian perspective. Our Canadian focus on dermatology makes us a leading manufacturer and supplier of topical products such as creams, ointments, and gels. This investment in niche markets continues to differentiate Taro from our competitors. We specialize in generic prescription products, but also produce over the counter and brand name drugs. Our strong research program and niche strategy have positioned us as a central player in the specialty pharmaceutical sector.

keywords:N/A

N/A

Total Funding

104

Number of Employees

$20.9M

Revenue (est)

30%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M1066%N/A
#2
$35M1091%N/A
#3
$13.8M115N/AN/A
#4
$11.6M116-32%N/A
#5
$28.4M1195%N/A